Wearable tech may outsmart the blood pressure cuff in preventing heart attacks
NCT ID NCT07770477
First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time
Summary
This trial compares two ways of managing high blood pressure: using a cuffless wearable device that tracks blood pressure continuously for 24 hours versus traditional office measurements. About 3,000 adults with high blood pressure will be randomly assigned to one of the two strategies. The goal is to see if the cuffless approach leads to fewer cardiovascular events like strokes, heart attacks, and heart failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cuffless ambulatory blood pressure monitoring device
- What this could lead to
- If successful, this approach could improve blood pressure control and reduce the risk of heart attacks, strokes, and other cardiovascular events in people with hypertension.
- What could go wrong
- The trial is large but still experimental; the cuffless device may not be as accurate as traditional cuffs, and the benefit over standard care is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Korea University Anam Hospital
Seoul, South Korea
-
Korea University Guro Hospital
Seoul, South Korea
-
Kyung Hee University Hospital at Gangdong
Seoul, South Korea
-
Kyungpook National University Hospital
Daegu, South Korea
-
Seoul National University Boramae Medical Center
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
-
The Catholic University of Korea, Uijeongbu St. Mary's Hospital
Uijeongbu-si, Gyeonggi-do, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood pressure drug shield hearts from secondhand smoke damage?
- Emergency room visit could be a turning point for metabolic health
- A new protocol after heart attacks could slash risk of repeat events
- Could talking it out lower blood pressure? coaching shows promise
- Can we stop early artery aging in kids with kidney disease?
- Can a few short nights of sleep tip the scales toward high blood pressure?